HIDRADENITIS SUPPURATIVA AND DIABETES MELLITUS: A SYSTEMATIC REVIEW
Keywords:
Alopecia areata, covid-19, hair lossAbstract
Objective: Hidradenitis suppurativa (HS), also known as acne inversus is a persistent inflammatory skin disease. This condition causes lesions such as deep-seated nodules and abscesses, draining tracts, and fibrotic scars. Preliminary data indicates a possible biological connection between diabetes mellitus (DM) and HS. This study aimed to review the correlation between hidradenitis suppurative and diabetes mellitus systematically.
Materials and methods: A systematic search strategy was conducted across several electronic reference databases (PubMed, Cochrane Library, ProQuest) and included articles published between 2019–2023. Duplicate publications, review articles, and incomplete articles were excluded.
Results: Database search yielded 214 articles, which were systematically eliminated, leaving 5 relevant articles. Analyzed articles showed the association between diabetes mellitus and hidradenitis suppurativa.
Conclusion: Studies support a significant relationship between HS and DM. Although the prevalence was variative, the association between the two conditions was significant.
References
Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm. Front Med. 2020;7(March):18–20.
Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):990–8.
Chandran NS, Lee JH, Kurokawa I. Hidradenitis suppurativa in South-East Asia and East Asia. Exp Dermatol. 2021;30(S1):23–6.
Napolitano M, Megna M, Timoshchuk EA, Patruno C, Balato N, Fabbrocini G, et al. Hidradenitis suppurativa: From pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105–15.
Kohorst JJ, Kimball AB, Davis MDP. Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol [Internet] 2015;73(5):S27–35. Available from: http://dx.doi.org/10.1016/j.jaad.2015.07.055
Frew JW. Hidradenitis suppurativa and diabetes: big data bias masks a true association. Clin Exp Dermatol. 2019;44(4):e151–2.
Jørgensen AHR, Yao Y, Ghazanfar MN, Ring HC, Thomsen SF. Burden, predictors and temporal relationships of comorbidities in patients with hidradenitis suppurativa: a hospital-based cohort study. J Eur Acad Dermatology Venereol. 2020;34(3):565–73.
Yüksel M, Basım P. Demographic and Clinical Features of Hidradenitis Suppurativa in Turkey. J Cutan Med Surg. 2020;24(1):55–9.
Reddy S, Strunk A, Garg A. Comparative Overall Comorbidity Burden among Patients with Hidradenitis Suppurativa. JAMA Dermatology. 2019;155(7):797–802.
Kluger N, Nuutinen P, Lybeck E, Ruohoalho T, Salava A. Type 2 diabetes mellitus in a cohort of Finnish patients with hidradenitis suppurativa. J Eur Acad Dermatology Venereol. 2020;34(2):e98–100.
Garg A, Birabaharan M, Strunk A. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States. J Am Acad Dermatol [Internet] 2018;79(1):71–6. Available from: https://doi.org/ 10.1016/j.jaad.2018.01.014
Brandão LAC, Tricarico PM, Gratton R, Agrelli A, Zupin L, Abou-Saleh H, et al. Multiomics integration in skin diseases with alterations in notch signaling pathway: PlatOMICs phase 1 deployment. Int J Mol Sci. 2021;22(4):1– 10.
Nguyen T V., Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatology Venereol. 2021;35(1):50–61.
Bettoli V, Naldi L, Cazzaniga S, Zauli S, Atzori L, Borghi A, et al. Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: Evidence from the national Italian registry. Br J Dermatol. 2016;174(1):195–7.
Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatol Clin [Internet] 2016;34(1):7–16. Available from: http://dx.doi.org/10.1016/j.det.2015.08.002
Jiang SW, Whitley MJ, Mariottoni P, Jaleel T, MacLeod AS. Hidradenitis Suppurativa: Host-Microbe and Immune Pathogenesis Underlie Important Future Directions. JID Innov [Internet] 2021;1(1):100001. Available from: https://doi.org/10.1016/j.xjidi.2021.100001
Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, et al. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol [Internet] 2022;86(5):1092–101. Available from: https://doi.org/10.1016/j.jaad.2021.01.059
Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis. Clin Exp Dermatol. 2019;44(4):e126–32.
González-López MA, Ocejo-Viñals JG, Mata C, Vilanova I, Guiral S, Portilla V, et al. Association of retinol binding protein4 (RBP4) and ghrelin plasma levels with insulin resistance and disease severity in non-diabetic patients with hidradenitis suppurativa. Exp Dermatol. 2020;29(9):828–32.
González-López MA, Vilanova I, Ocejo-Viñals G, Arlegui R, Navarro I, Guiral S, et al. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa. Arch Dermatol Res [Internet] 2020;312(8):595–600. Available from: https://doi.org/10.1007/s00403-019-02018-4
Bui TL, Silva-Hirschberg C, Torres J, Armstrong AW. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis. J Am Acad Dermatol [Internet] 2018;78(2):395–402. Available from: https://doi.org/ 10.1016/j.jaad.2017.08.042
Karagiannidis I, Nikolakis G, Zouboulis CC. Endocrinologic Aspects of Hidradenitis Suppurativa. Dermatol Clin. 2016;34(1):45–9.
Edigin E, Kaul S, Eseaton PO. Analysis of hidradenitis suppurativa hospitalizations: A report from the National Inpatient Sample database. J Am Acad Dermatol. 2021;85(5):1357–60.
Ahmad S, Riddle AO, Sayed CJ. Outcomes of Routine Diabetes Screening for Patients with Hidradenitis Suppurativa. J Invest Dermatol. 2021;141(4):927–30.
Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178(4):917–24.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
